Hide metadata

dc.date.accessioned2021-04-24T19:34:45Z
dc.date.available2021-04-24T19:34:45Z
dc.date.created2021-01-29T07:30:05Z
dc.date.issued2020
dc.identifier.citationBorja, Austin J Hancin, Emily C. Dreyfuss, Alexandra D Zhang, Vincent Mathew, Toby Rojulpote, Chaitanya Werner, Thomas J. Shivaraj, Patil Gonuguntla, Karthik Lin, Alexander Feigenberg, Steven J Swisher-McClure, Samuel Alavi, Abass Rootwelt-Revheim, Mona-Elisabeth . 18F-FDG-PET/CT in the quantification of photon radiation therapy-induced vasculitis. The American Journal of Nuclear Medicine and Molecular Imaging (AJNMMI). 2020, 10(1), 66-73
dc.identifier.urihttp://hdl.handle.net/10852/85562
dc.description.abstractRadiation therapy (RT) is an important component of care for head and neck cancers (HNC). Photon RT vasculitis is a complication of incidental dose delivery to nearby vascular structures. However, optimal methods for early diagnosis are not clearly established. The aim of this study was to evaluate 18F-FDG-PET/CT in detecting radiation-induced vasculitis of the left common carotid (LCC) and the arch of the aorta (AoA) in patients treated for HNC. 18F-FDG-PET/CT scans obtained before RT (Pre-RT) and 3 months after RT (Post-RT) were retrospectively reviewed in 30 HNC patients (25 males, 5 females; average age 57.9±8.1 years) treated with photon RT. All subjects underwent 18F-FDG-PET/CT imaging 60 minutes after 5.0 MBq/kg 18F-FDG injection. Average standard uptake values (Avg SUVmean) of the LCC and AoA were obtained by global assessment. A two-tailed paired t-test was used to assess the difference in Avg SUVmean between pre- and post-RT imaging. Subjects demonstrated significant increased Avg SUVmean within the LCC post-RT (pre = 1.42, post = 1.65, P<0.001), with a mean increase of 0.23 SUV. Similarly, subjects exhibited higher 18F-FDG uptake in the AoA post-RT (pre = 1.44, post = 1.69, P<0.01), with a mean increase of 0.23 SUV. 18F-FDG-PET/CT may be used to detect and quantify photon RT vasculitis in HNC patients. Further investigation is warranted to evaluate the clinical implications of this pathology and the role for alternative treatment strategies in minimizing tissue toxicity.
dc.languageEN
dc.publisherE-Century Publishing Corporation
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.title18F-FDG-PET/CT in the quantification of photon radiation therapy-induced vasculitis
dc.typeJournal article
dc.creator.authorBorja, Austin J
dc.creator.authorHancin, Emily C.
dc.creator.authorDreyfuss, Alexandra D
dc.creator.authorZhang, Vincent
dc.creator.authorMathew, Toby
dc.creator.authorRojulpote, Chaitanya
dc.creator.authorWerner, Thomas J.
dc.creator.authorShivaraj, Patil
dc.creator.authorGonuguntla, Karthik
dc.creator.authorLin, Alexander
dc.creator.authorFeigenberg, Steven J
dc.creator.authorSwisher-McClure, Samuel
dc.creator.authorAlavi, Abass
dc.creator.authorRootwelt-Revheim, Mona-Elisabeth
cristin.unitcode185,53,63,10
cristin.unitnameAvdeling for radiologi-nukleærmedisin
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1881867
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=The American Journal of Nuclear Medicine and Molecular Imaging (AJNMMI)&rft.volume=10&rft.spage=66&rft.date=2020
dc.identifier.jtitleThe American Journal of Nuclear Medicine and Molecular Imaging (AJNMMI)
dc.identifier.volume10
dc.identifier.issue1
dc.identifier.startpage66
dc.identifier.endpage73
dc.identifier.urnURN:NBN:no-88238
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn2160-8407
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/85562/2/ajnmmi0010-0066.pdf
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial 4.0 International
This item's license is: Attribution-NonCommercial 4.0 International